0001209191-18-060103.txt : 20181128 0001209191-18-060103.hdr.sgml : 20181128 20181128160326 ACCESSION NUMBER: 0001209191-18-060103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181127 FILED AS OF DATE: 20181128 DATE AS OF CHANGE: 20181128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ORDONEZ KATHY CENTRAL INDEX KEY: 0001222643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34899 FILM NUMBER: 181205675 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS STREET 2: C/O QUEST DIAGNOSTICS CITY: MADISON STATE: NJ ZIP: 07940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CENTRAL INDEX KEY: 0001299130 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 161590339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-521-8000 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC DATE OF NAME CHANGE: 20050829 FORMER COMPANY: FORMER CONFORMED NAME: NANOFLUIDICS INC DATE OF NAME CHANGE: 20040729 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-27 0 0001299130 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB 0001222643 ORDONEZ KATHY PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 1305 O'BRIEN DRIVE MENLO PARK CA 94025 1 1 0 0 Chief Commercial Officer Common Stock 2018-11-27 4 M 0 25000 2.90 A 68750 D Common Stock 2018-11-27 4 S 0 25000 7.54 D 43750 D Stock Option (right to buy) 2.90 2018-11-27 4 A 0 25000 0.00 D 2017-12-15 2027-11-15 Common Stock 25000 350000 D This sale price represents the weighted average sale price of the shares sold ranging from $7.54 to $7.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The shares subject to the option will vest in equal monthly installments over a four year period. /s/ Stephen Moore, Attorney-in-fact for Kathy Ordonez 2018-11-28